YGT-31
YGT-31 is a modulator for PPARγ with an IC50 of 1.72 μM, and a Ki of 0.62 μM. YGT-31 reduces blood glucose levels and improves insulin resistance in db/db mice type 2 diabetes models, through inhibition of CDK5-mediated PPARγ-Ser273 phosphorylation. YGT-31 exhibits anti-hepatic steatosis effect in mice non-alcoholic fatty liver disease (NAFLD) model[1].
Product Specifications
CAS Number
2835447-74-8
UNSPSC
12352005
Target
PPAR
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/ygt-31.html
Smiles
OC1=CC(OCC(NCC2=CC=C(C(F)(F)F)C=C2)=O)=CC3=C1C(C=C(O3)C4=CC=CC=C4)=O
Molecular Formula
C25H18F3NO5
Molecular Weight
469.41
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PPARγ
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
![PerCP/Cyanine 5.5 Anti-Human Ki-67 Antibody[3B7]](https://cdn.genprice.uk/genprice/uk/genprice3.webp)
PerCP/Cyanine 5.5 Anti-Human Ki-67 Antibody[3B7]
PerCP/Cyanine 5.5 Anti-Human Ki-67 Antibody[3B7]
PerCP/Cyanine 5.5 Anti-Human Ki-67 Antibody[3B7]
